AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BARICITINIB 2 Mg ;

9 registrations across 1 African market— 9 active

Markets with BARICITINIB 2 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Barictomap 2 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Barictomap 2 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Exliance
Film Coated Tablets
🇪🇬Egyptexcellence pharmactive
Barcimiant 2mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Baritava 2mg
Film Coated Tablets
🇪🇬EgyptHikma pharmaactive
Baritava 2mg
Film Coated Tablets
🇪🇬EgyptHikma pharmaactive
Andomatoid 2 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Barcimiant 2mg
Film Coated Tablets
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Andomatoid 2 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive

BARICITINIB 2 Mg ; in Africa — Regulatory Overview

BARICITINIB 2 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.